#355: Mastering the Pitch: MedTech Innovations from Concept to Market

Global Medical Device Podcast · 15 Feb 2024 · 40m · Episode 355

What this episode covers

Blythe Karow, COO at Neurogeneces and former president/COO at Evren Technologies, shares her extensive experience pitching to investors, including securing an FDA breakthrough designation for Evren's spinal cord stimulation device. She emphasizes the importance of tailoring pitches to specific audiences, starting with the problem in the voice of the payer, and managing team dynamics during presentations. Karow also discusses the emotional aspects of pitching, such as handling nervousness and gender dynamics, while advising founders to practice extensively and utilize resources like Springboard Digital Health Innovation Program.

Mentioned

Companies
Neurogeneces, Evren Technologies, Boston Scientific, Greenlight Guru
Also
Springboard Digital Health Innovation Program, Medtech Innovator

Other shows on the same ground, closest first.

  • Being an Engineer · 28m

    S4E41 Neil Thompson | Technical Pitches: Revealing Flaws, Using Stories, & Wiggling Toes

    Neil Thompson, founder of Teach the Geek and creator of the Teach the Geek Pitching Society, explains how technical founders can improve their investor pitches by focusing on empathy, storytelling, and transparency. He advises entrepreneurs to practice for less time than allotted, use stories to convey benefits rather than just features, and openly discuss product flaws to build trust with investors. The conversation highlights specific techniques for managing presentation anxiety, such as wiggling toes or wearing sweaters, and emphasizes that investors are investing in the team's ability to solve problems.

  • Being an Engineer · 40m

    S2E40 Voice of the Customer, Using Questions, and the Technology Adoption Life Cycle Curve | Ted Newill

    Ted Newill, founder of Medical Device Success and SRD Vision, discusses the critical importance of 'Voice of the Customer' and the Technology Adoption Life Cycle Curve for medtech startups. He explains how engineers can bridge the gap between regulatory approval and commercialization by identifying early adopters and key opinion leaders before launch. Newill also shares advice on managing the pressure of venture-funded environments and the necessity of empathy and listening when collaborating with marketing and sales teams.

  • Being an Engineer · 39m

    S4E47 Mark Byrne | Startup Engineering, Funding, & Assumptions

    Mark Byrne, founder of PriMedicus Development, discusses his experience leading early-stage life sciences and medical device companies, covering strategies for market validation, securing funding, and managing engineering teams. He emphasizes the importance of direct customer interaction over third-party research, using development contracts with early adopters to de-risk technology before seeking venture capital. Byrne also shares lessons from a failed food safety sensor project and a successful genetic testing product licensed from Mayo Clinic, highlighting the critical role of technical expertise and customer relationships in startup success.

  • The Hardware Story · 1h 22m

    Episode 1 - The Hardware Story of Inito w/ Aayush Rai | Building a B2C medical hardware company

    Aayush Rai, Co-Founder and CEO of Inito, discusses building a B2C medical hardware company from Bangalore, India, targeting the US market with a home fertility monitoring device. He details the journey from prototyping with Arduino to navigating FDA regulations, securing $15M in funding through a unique angel-first strategy, and the critical pivot to focus exclusively on the iOS ecosystem to achieve product-market fit.

  • Let's Combinate · 1h 07m

    017 - "Feet First" with Ahmed Zobi

    Ahmed Zobi, Founder and CEO of Syntr Health Technologies, explains how he bootstrapped his company from a university project to FDA 510(k) clearance for the SyntrFuge System, a device that automates the microsizing of adipose tissue for body contouring and wound care. Zobi details the strategic decision to target aesthetics and orthopedics first to generate revenue while pursuing diabetic foot ulcer indications, and describes the intense personal sacrifices made during the grant submission process and the COVID-19 pandemic. He emphasizes the importance of leveraging mentors, conducting customer discovery through the NSF iCorps program, and building a robust quality management system early to navigate regulatory requirements.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.